Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Amoxicillin; Clavulanic acid
Instituto Biochimico Italiano G. Lorenzini S.p.A.
J01CR; J01CR02
Amoxicillin; Clavulanic acid
2000 mg/200 milligram(s)
Powder for solution for infusion
Combinations of penicillins, incl. beta-lactamase inhibitors; amoxicillin and enzyme inhibitor
Not marketed
2019-11-22
PACKAGE LEAFLET: INFORMATION FOR THE USER CO-AMOXICLAV 2000 MG/200 MG POWDER FOR SOLUTION FOR INFUSION Amoxicillin/Clavulanic acid READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Co-amoxiclav is and what it is used for 2. What you need to know before you are given Co-amoxiclav 3. How Co-amoxiclav is given 4. Possible side effects 5. How to store Co-amoxiclav 6. Contents of the pack and other information 1. WHAT CO-AMOXICLAV IS AND WHAT IT IS USED FOR Co-amoxiclav is an antibiotic and works by killing bacteria that cause infections. It contains two different medicines called amoxicillin and clavulanic acid. Amoxicillin belongs to a group of medicines called “penicillins” that can sometimes be stopped from working (made inactive). The other active component (clavulanic acid) stops this from happening. Co-amoxiclav is used in adults and children to treat the following infections: • severe ear, nose and throat infections • respiratory tract infections • urinary tract infections • skin and soft tissue infections including dental infections • bone and joint infections • intra-abdominal infections • genital organ infections in women Co-amoxiclav is also used in adults and children to prevent infections associated with major surgical procedures. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN CO-AMOXICLAV YOU SHOULD NOT HAVE CO-AMOXICLAV • if you are allergic to amoxicillin, clavulanic acid or penicillin. • if you have ever had a severe allergic reaction to any other antibiotic. This can include a skin rash or swelling of the face or throat. • if you have ever had liver problems or jaundice (yellowing of the ski Read the complete document
Health Products Regulatory Authority 20 October 2023 CRN00DRZ5 Page 1 of 13 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Co-amoxiclav 2000 mg/200 mg powder for solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 2000 mg amoxicillin (as amoxicillin sodium) and 200 mg clavulanic acid (as potassium clavulanate) Each vial contains 5.5 mmol (125.9 mg) of sodium Each vial contains 1 mmol (39.3 mg) of potassium 3 PHARMACEUTICAL FORM Powder for solution for infusion White powder 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Co-amoxiclav is indicated for the treatment of the following infections in adults and children (see sections 4.2, 4.4 and 5.1): -severe infections of the ear, nose and throat (such as mastoiditis, peritonsillar infections, epiglottitis, and sinusitis when accompanied by severe systemic signs and symptoms) -acute exacerbations of chronic bronchitis (adequately diagnosed) -community acquired pneumonia -cystitis -pyelonephritis -skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis -bone and joint infections, in particular osteomyelitis -intra-abdominal infections -female genital infections Prophylaxis against infections associated with major surgical procedures in adults, such as those involving the: -gastrointestinal tract -pelvic cavity -head and neck -biliary tract surgery Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Doses are expressed throughout in terms of amoxicillin/clavulanic acid content except when doses are stated in terms of an individual component. The dose of amoxicillin/clavulanic acid that is selected to treat an individual infection should take into account: -the expected pathogens and their likely susceptibility to antibacterial agents (see section 4.4) -the severity and the site of the infection -the age, weight and renal function of the patient as shown bel Read the complete document